SAFC Pharma’s new reactor at its Arklow, manufacturing site has begun operation, expanding the facility’s capacity for large-scale active pharmaceutical ingredient (API) manufacturing by approximately 15%. The $4 million project involved the installation and start-up of a 6,000 liter Hastalloy reactor for large-scale API manufacturing, increasing the total capacity at the site to 96,000 liters, with a reactor range from 250 to 8,000 liters. This adds capacity for both large- and sm...